ProMIS Neurosciences, Inc. (PMN)
R&D Expense Growth
36.59%
Quarterly · Period ending:
PMN R&D Expense Growth
Latest reported36.59%period ending
Latest reported36.59%period ending
PMN Quarterly R&D Growth (QoQ) (0.00% → 36.59%)
Latest values, visible window
High-resolution chart · PNG
PMN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 36.5914% | |
| -25.586% | |
| -4.3843% | |
| 11.9733% | |
| 60.1278% | |
| 26.3526% | |
| 68.6811% | |
| 57.691% | |
| -23.4468% | |
| -4.5509% | |
| 94.8097% | |
| -14.2737% | |
| -71.9374% | |
| -44.6528% | |
| 36.911% | |
| 50.6723% | |
| 74.9003% | |
| -21.4518% | |
| 275.8232% | |
| -5.8182% | |
| 209.8501% | |
| 7.4268% | |
| -75.6202% | |
| 17.2304% | |
| -7.6726% | |
| 12.0451% | |
| -17.4908% | |
| 1.0076% | |
| -21.3712% | |
| -61.1741% | |
| 136.2618% | |
| 24.1869% | |
| 115.3566% | |
| 11.0194% | |
| -51.0304% | |
| 14.197% | |
| 56.7507% | |
| -21.212% | |
| 88.1012% | |
| 53.91% | |
| -12.5648% | |
| 18.9919% | |
| -14.2562% | |
| 200.8156% | |
| -50.4927% | |
| -55.144% | |
| 7.535% | |
| -24.689% | |
| 47.0302% | |
| 23.5056% | |
| -11.7283% | |
| -25.6293% | |
| -2.054% | |
| 3.849% | |
| -9.5357% | |
| 1.291% | |
| 80,472.6098% | |
| -99.9008% | |
| 14.4603% | |
| 15.6076% | |
| -35.6248% | |
| 9.5287% | |
| -10.2801% | |
| -52.5204% | |
| 50.8991% | |
| 6.0645% | |
| -2.4647% | |
| 20.8102% | |
| 0.8364% | |
| 13.6864% | |
| -21.3811% | |
| -37.3628% | |
| -7.8875% | |
| 6.3457% | |
| -18.4414% | |
| 16.7361% | |
| 14.6497% | |
| 109.5278% | |
| 2.1259% | |
| 4.8309% | |
| 38.8329% | |
| 55.9565% | |
| 39.961% | |
| 100.2373% | |
| 0% |